Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
4.470
+0.010 (0.22%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Silo Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.070.070.070.070.070.07
Revenue Growth
0%0%0%0%1.18%-
Gross Profit
0.010.030.070.070.070.07
Operating Income
-4.78-4.28-4.71-3.86-3.63-2.74
Net Income
-4.84-4.23-4.39-3.77-7.542.5
Earnings Per Share
-6.45-7.50-17.85-18.00-25.6521.45
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.217.087.087.6711.3710.26
Total Debt
000000
Net Cash (Debt)
6.217.087.087.6711.3710.26
Net Cash Growth
13.84%0.00%-7.63%-32.58%10.85%824.31%
Net Cash Per Share
8.7212.6728.8637.3374.6680.20

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.84-4.66-3.83-3.22-3.5-2.28
Free Cash Flow
-3.84-4.66-3.83-3.22-3.5-2.28
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
11.90%38.57%91.90%91.90%91.90%92.98%
Operating Margin
-6631.16%-5936.95%-6526.44%-5347.41%-5031.28%-3850.95%
Pretax Margin
-6717.40%-5863.50%-6092.59%-5036.04%-5419.25%5868.30%
Profit Margin
-6717.40%-5863.50%-6092.59%-5036.04%-10450.50%1982.44%
FCF Margin
-5330.87%-6464.92%-5317.35%-4472.13%-4850.94%-3196.59%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----0.10
PS Ratio
67.2362.8055.3558.04147.203.96